Volcano is acquiring Sync-Rx, an Israeli software developer that focuses on coronary catheterizations, in a deal reported to total $17.3 million.
Volcano announced Nov. 23 that it entered into a definitive agreement to acquire the privately-held company and anticipated the transaction will close within the next 30 days. Netanya, Israel-based Sync-Rx develops software applications and manufactures image-guided therapy tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease.
Its products include the Sync-Rx System, an add-on online image processing workstation for coronary catheterizations that has received FDA 510(k) clearance and CE Mark in Europe.
Scott Huennekens, Volcano’s president and CEO, described the transaction as a move to advance Volcano’s platform and broaden the San Diego-based company’s reach in Israel. He added that the acquisition will allow Volcano to build software features to assist in clinical decision-making by providing angiography and intra-body image enhancement.